Australia's most trusted
source of pharma news
Posted 15 November 2024 PM
Nearly 15 years after founding, BeiGene is looking to change its name to BeOne Medicines with an accompanying new logo to better reflect its vision to unite the worldwide community in the fight against cancer.
The 'Be' component "represents the fundamental goal of any patient with cancer - simply to be free of disease," the company said in a statement, while the 'One' emphasises its "unity as a team and focus on bringing together patients, caregivers, scientists, healthcare providers, governments and industry with a shared mission to eliminate cancer together".
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.